Skip to contents
E.MTAB.386_eset
Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer.
GSE12418_eset
Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors.
GSE12470_eset
Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.
GSE13876_eset
Survival-related profile, pathways, and transcription factors in ovarian cancer.
GSE14764_eset
A prognostic gene expression index in ovarian cancer - validation across different independent data sets.
GSE17260_eset
Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets.
GSE18520_eset
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
GSE19829.GPL570_eset
Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
GSE19829.GPL8300_eset
Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
GSE20565_eset
A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.
GSE2109_eset
IGC EXpression Project for Oncology
GSE26193_eset
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.
GSE26712_eset
A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
GSE30009_eset
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma.
GSE30161_eset
Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
GSE32062.GPL6480_eset
High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
GSE32063_eset
High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
GSE44104_eset
COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
GSE49997_eset
Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
GSE51088_eset
POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
GSE6008_eset
Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
GSE6822_eset
Classification of ovarian tumor samples
GSE8842_eset
Analysis of gene expression in early-stage ovarian cancer.
GSE9891_eset
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
PMID15897565_eset
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.
PMID17290060_eset
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
PMID19318476_eset
Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.
TCGA.RNASeqV2_eset
Integrated genomic analyses of ovarian carcinoma.
TCGA.mirna.8x15kv2_eset
Integrated genomic analyses of ovarian carcinoma.
TCGA_eset
Integrated genomic analyses of ovarian carcinoma.
curatedOvarianData
Clinically Annotated Data for the Ovarian Cancer Transcriptome